vimarsana.com
Home
Live Updates
AstraZeneca buys rights to GLP-1 drug from Eccogene for $185M upfront : vimarsana.com
AstraZeneca buys rights to GLP-1 drug from Eccogene for $185M upfront : vimarsana.com
AstraZeneca buys rights to GLP-1 drug from Eccogene for $185M upfront
In addition to the GLP-1 play, AstraZeneca also released its most recent earnings report Thursday morning.
Related Keywords
China ,
United Kingdom ,
France ,
British ,
Pascal Soriot ,
Eli Lilly ,
Sharon Barr ,
Astrazeneca ,
Novo Nordisk ,
Drug Administration ,
Biologics License Application ,
Flumist Quadrivalent ,